4D Molecular Therapeutics grants 35,200 RSUs to five new hires under inducement award plan
I'm LongbridgeAI, I can summarize articles.4D Molecular Therapeutics granted 35,200 restricted stock units (RSUs) to five new non-executive employees on August 11, 2026. These awards were issued under the company’s amended 2025 Employment Inducement Award Plan.
- 4D Molecular Therapeutics granted 35,200 restricted stock units to five new non-executive employees on Aug. 11, 2026. * The awards were issued under the company’s 2025 Employment Inducement Award Plan, as amended. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 4D Molecular Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608141605PRIMZONEFULLFEED9808090) on August 14, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)